Gelteq Limited shareholders approved a $3.5 million debt financing proposal at a special meeting on June 18, 2026. Following approval, the company closed the second tranche of the financing, receiving $2.5 million in net proceeds from an institutional investor on June 26, 2026. Gelteq Limited is an Australian-based company that provides technology solutions for the healthcare sector.

Gelteq Limited filed a 6-K to disclose its unaudited financial results for the six-month period ending December 31, 2025, including management's discussion and analysis and condensed consolidated financial statements. Gelteq Limited is an Australian-based company that provides technology solutions for the medical and medical device industry.